Quest Partners LLC Has $812,000 Position in Schrödinger, Inc. (NASDAQ:SDGR)

Quest Partners LLC lifted its position in shares of Schrödinger, Inc. (NASDAQ:SDGR) by 861.0% in the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 43,773 shares of the company’s stock after buying an additional 39,218 shares during the quarter. Quest Partners LLC’s holdings in Schrödinger were worth $812,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently made changes to their positions in SDGR. Nisa Investment Advisors LLC boosted its holdings in shares of Schrödinger by 145.3% in the 2nd quarter. Nisa Investment Advisors LLC now owns 1,413 shares of the company’s stock valued at $27,000 after purchasing an additional 837 shares in the last quarter. GAMMA Investing LLC boosted its position in shares of Schrödinger by 49.5% during the 2nd quarter. GAMMA Investing LLC now owns 2,124 shares of the company’s stock worth $41,000 after purchasing an additional 703 shares in the last quarter. KBC Group NV increased its stake in Schrödinger by 45.4% during the 3rd quarter. KBC Group NV now owns 2,508 shares of the company’s stock valued at $47,000 after purchasing an additional 783 shares in the last quarter. nVerses Capital LLC purchased a new stake in shares of Schrödinger in the second quarter worth approximately $66,000. Finally, Private Advisor Group LLC grew its stake in shares of Schrödinger by 20.5% in the 3rd quarter. Private Advisor Group LLC now owns 12,150 shares of the company’s stock worth $225,000 after acquiring an additional 2,065 shares in the last quarter. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Schrödinger

In related news, insider Margaret Dugan sold 1,531 shares of the business’s stock in a transaction on Tuesday, October 15th. The shares were sold at an average price of $17.78, for a total value of $27,221.18. Following the completion of the transaction, the insider now directly owns 13,469 shares in the company, valued at $239,478.82. The trade was a 10.21 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Corporate insiders own 8.60% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts recently commented on SDGR shares. BMO Capital Markets increased their price target on Schrödinger from $25.00 to $28.00 and gave the company an “outperform” rating in a research report on Wednesday, November 13th. Morgan Stanley dropped their target price on shares of Schrödinger from $43.00 to $30.00 and set an “equal weight” rating on the stock in a research note on Wednesday, August 21st. Three analysts have rated the stock with a hold rating, seven have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $32.90.

Schrödinger Trading Up 6.3 %

Shares of SDGR opened at $20.39 on Friday. The business’s fifty day simple moving average is $18.63 and its two-hundred day simple moving average is $20.25. The company has a market cap of $1.48 billion, a price-to-earnings ratio of -8.71 and a beta of 1.50. Schrödinger, Inc. has a 12 month low of $16.67 and a 12 month high of $38.00.

Schrödinger (NASDAQ:SDGR) last issued its earnings results on Tuesday, November 12th. The company reported ($0.52) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.40) by ($0.12). Schrödinger had a negative return on equity of 35.77% and a negative net margin of 91.84%. The firm had revenue of $35.30 million during the quarter, compared to the consensus estimate of $41.25 million. During the same period last year, the firm posted ($0.86) earnings per share. The company’s revenue for the quarter was down 17.1% compared to the same quarter last year. As a group, research analysts forecast that Schrödinger, Inc. will post -2.29 EPS for the current year.

Schrödinger Company Profile

Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.